Letter to the Editor
Dear Editor,
in their comment to our case report on a one-year-old male presenting anaphylactic shock episodes triggered by intravenous administration of methylprednisolone sodium succinatum, Kounis et al., highlighted a poor-known clinical entity determined by systemic use of corticosteroids (the so-called “Kounis syndrome type I”) [1]. Authors have furtherly raised the important issue of high risk of adverse drug reaction in patients with atopic diathesis.
Anzeige
We thank the Authors for having provided a comprehensive overview on pharmacodynamic profile of corticosteroids and the main mechanisms underpinning the most frequent adverse reactions to these common-used drugs.
As already exhaustively reported, two type of hypersensitivity reactions to systemic steroid administration should be mainly considered: immediate (IgE-mediated) and delayed (T cell-mediated) reactions [2].
Because of the risk of life-threatening reactions, to investigate mechanisms underlying immediate steroid allergic reactions is of great interest into scientific community.
The native drug-molecule or a drug metabolite (hapten) may act as an allergen. Moreover, esters used to create soluble injectable preparations (sodium succinate and sodium phosphate) can, sometimes, justify the allergic reactions rather than the glucocorticoid itself. Finally, glucocorticoid preparations may contain preservatives and excipients (e.g. lactose, carboxymethylcellulose, polyethylene glycol, hexylene glycol) to which sensitized patients can react [2].
Anzeige
In our case report, the anaphylactic shock occurred in a cow’s milk allergic patient, after the administration of systemic steroid formulation containing lactose and cow’s milk proteins traces. Although the first allergic reaction was attributed to the antibiotic treatment, the next episode clarified the cause-effect relationship allowing the diagnosis.
The delayed diagnosis of immediate allergic reaction to steroid is another important issue. In fact, patients typically receive glucocorticoids for several clinical conditions (asthma, anaphylaxis or shock) which present signs and symptoms similar to those of allergic reactions. Therefore, it can be difficult to distinguish a progressively worsening of medical condition from a superimposed allergic reaction to a glucocorticoid.
In conclusion, we agree with the Authors on the need to administer corticosteroids with caution in patients suffering from atopic disease.
Acknowledgements
Not available.
Funding
None.
Availability of data and materials
Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Ethics approval and consent to participate
Not required.
Consent for publication
Not required.
Anzeige
Competing interests
The authors declare that they have no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.